Zoar files Form F-4 for Impact Biomedical business combination

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. HOOD
9. INTC
10. JBLU

Go back to Zoar files Form F-4 for Impact Biomedical business combination

DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited

September 16, 2026 9:25 AM EDT

ROCHESTER, N.Y., Sept. 16, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (DSS or the Company) today announced that Zoar Limited (Zoar or PubCo) has filed a Registration Statement on Form F-4 (the Registration Statement) with the U.S. Securities and Exchange Commission (SEC) in connection with the previously announced proposed business combination (the Business Combination) involving Impact Biomedical Inc. (NYSE American: IBO) (Impact), Zoar and certain related parties.

DSS is a significant stockholder of Impact Biomedical, and the filing represents an important step in Impacts proposed Business Combination with Zoar.

... More